Patricia Hartge

45.9k total citations · 7 hit papers
241 papers, 18.7k citations indexed

About

Patricia Hartge is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Patricia Hartge has authored 241 papers receiving a total of 18.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 56 papers in Pathology and Forensic Medicine and 41 papers in Genetics. Recurrent topics in Patricia Hartge's work include Lymphoma Diagnosis and Treatment (44 papers), Ovarian cancer diagnosis and treatment (33 papers) and Cancer Risks and Factors (28 papers). Patricia Hartge is often cited by papers focused on Lymphoma Diagnosis and Treatment (44 papers), Ovarian cancer diagnosis and treatment (33 papers) and Cancer Risks and Factors (28 papers). Patricia Hartge collaborates with scholars based in United States, Sweden and Australia. Patricia Hartge's co-authors include Lindsay M. Morton, Susan S. Devesa, James R. Cerhan, Martha S. Linet, Robert N. Hoover, Margaret A. Tucker, Richard K. Severson, Sholom Wacholder, Sophia Wang and Joanne S. Colt and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Patricia Hartge

240 papers receiving 18.1k citations

Hit Papers

The Risk of Cancer Associated with Specific Mutations ofB... 1997 2026 2006 2016 1997 2005 2015 2013 2004 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Hartge United States 68 4.5k 3.8k 3.5k 2.8k 2.7k 241 18.7k
Garnet L. Anderson United States 62 4.9k 1.1× 1.9k 0.5× 4.4k 1.3× 2.2k 0.8× 2.4k 0.9× 218 16.4k
Jean Wactawski‐Wende United States 77 5.0k 1.1× 3.4k 0.9× 4.5k 1.3× 4.0k 1.4× 2.7k 1.0× 467 21.5k
Jørgen H. Olsen Denmark 84 5.1k 1.1× 2.6k 0.7× 2.5k 0.7× 4.0k 1.4× 3.7k 1.4× 517 27.6k
Yu‐Tang Gao United States 76 5.2k 1.2× 3.3k 0.9× 3.1k 0.9× 4.7k 1.7× 5.7k 2.1× 444 21.1k
Polly A. Newcomb United States 68 8.9k 2.0× 3.8k 1.0× 3.6k 1.0× 1.9k 0.7× 2.8k 1.1× 371 17.8k
Elisabete Weiderpass Sweden 75 8.0k 1.8× 1.8k 0.5× 2.3k 0.7× 4.5k 1.6× 3.5k 1.3× 508 26.8k
Lynn Rosenberg United States 88 5.1k 1.1× 1.6k 0.4× 4.3k 1.3× 5.1k 1.8× 3.4k 1.3× 628 28.2k
Franco Berrino Italy 73 7.6k 1.7× 2.3k 0.6× 2.8k 0.8× 3.6k 1.3× 3.4k 1.3× 310 18.1k
W. Dana Flanders United States 75 3.2k 0.7× 1.7k 0.5× 2.4k 0.7× 3.3k 1.2× 2.8k 1.1× 366 24.2k
Valerie Beral United Kingdom 84 9.7k 2.1× 3.6k 0.9× 6.9k 2.0× 5.7k 2.0× 3.3k 1.2× 343 33.2k

Countries citing papers authored by Patricia Hartge

Since Specialization
Citations

This map shows the geographic impact of Patricia Hartge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Hartge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Hartge more than expected).

Fields of papers citing papers by Patricia Hartge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Hartge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Hartge. The network helps show where Patricia Hartge may publish in the future.

Co-authorship network of co-authors of Patricia Hartge

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Hartge. A scholar is included among the top collaborators of Patricia Hartge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Hartge. Patricia Hartge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edin, Matthew L., Patricia Hartge, Fred B. Lih, et al.. (2018). Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiology Biomarkers & Prevention. 28(1). 189–197. 34 indexed citations
2.
McGuire, Valerie, Patricia Hartge, Linda M. Liao, et al.. (2016). Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1059–1063. 18 indexed citations
3.
Carter, Brian D., Christian C. Abnet, Diane Feskanich, et al.. (2015). Smoking and Mortality — Beyond Established Causes. New England Journal of Medicine. 372(7). 631–640. 540 indexed citations breakdown →
4.
Shiels, Meredith S., Eric A. Engels, Martha S. Linet, et al.. (2013). The Epidemic of Non–Hodgkin Lymphoma in the United States: Disentangling the Effect of HIV, 1992–2009. Cancer Epidemiology Biomarkers & Prevention. 22(6). 1069–1078. 87 indexed citations
5.
Hyer, Marianne, Ruth M. Pfeiffer, Ervin Adam, et al.. (2012). Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol. Obstetrical & Gynecological Survey. 67(2). 94–96. 39 indexed citations
6.
Murphy, Megan, Britton Trabert, Hannah Yang, et al.. (2012). Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review. Cancer Causes & Control. 23(11). 1839–1852. 27 indexed citations
7.
Wang, Sophia, Idan Menashe, James R. Cerhan, et al.. (2011). Variations in Chromosomes 9 and 6p21.3 with Risk of Non–Hodgkin Lymphoma. Cancer Epidemiology Biomarkers & Prevention. 20(1). 42–49. 18 indexed citations
8.
Wang, Sophia, Yani Lu, Nathaniel Rothman, et al.. (2011). Variation in Effects of Non-Hodgkin Lymphoma Risk Factors According to the Human Leukocyte Antigen (HLA)-DRB1*01:01 Allele and Ancestral Haplotype 8.1. PLoS ONE. 6(11). e26949–e26949. 17 indexed citations
9.
Purdue, Mark P., Berit Bakke, Patricia A. Stewart, et al.. (2010). A Case–Control Study of Occupational Exposure to Trichloroethylene and Non-Hodgkin Lymphoma. Environmental Health Perspectives. 119(2). 232–238. 45 indexed citations
10.
Greenlee, Robert T., Bruce Kessel, Craig Williams, et al.. (2010). Prevalence, Incidence, and Natural History of Simple Ovarian Cysts Among Women >55 Years Old in a Large Cancer Screening Trial. Obstetrical & Gynecological Survey. 65(6). 373–374. 1 indexed citations
11.
Wang, Sophia, James R. Cerhan, Patricia Hartge, et al.. (2006). Common Genetic Variants in Proinflammatory and Other Immunoregulatory Genes and Risk for Non-Hodgkin Lymphoma. Cancer Research. 66(19). 9771–9780. 105 indexed citations
12.
Cozen, Wendy, David V. Conti, Gerhard A. Coetzee, et al.. (2006). Interleukin-6 Related Genotypes, Body Mass Index and Risk of Multiple Myeloma. 13(3). 26. 1 indexed citations
13.
Kelemen, Linda E, James R. Cerhan, Unhee Lim, et al.. (2006). Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute–Surveillance, Epidemiology, and End Results population-based case-control study. American Journal of Clinical Nutrition. 83(6). 1401–1410. 54 indexed citations
14.
Colt, Joanne S., Richard K. Severson, Jay H. Lubin, et al.. (2005). Organochlorines in Carpet Dust and Non-Hodgkin Lymphoma. Epidemiology. 16(4). 516–525. 96 indexed citations
15.
Hill, Deirdre A., Sophia Wang, Patricia Hartge, et al.. (2005). Risk of Non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair genes. Cancer Research. 65. 966–966. 2 indexed citations
16.
Engels, Eric A., Dana E. Rollison, Patricia Hartge, et al.. (2005). Antibodies to JC and BK viruses among persons with non‐Hodgkin lymphoma. International Journal of Cancer. 117(6). 1013–1019. 32 indexed citations
17.
Wacholder, Sholom, Nilanjan Chatterjee, & Patricia Hartge. (2002). Joint Effect of Genes and Environment Distorted by Selection Biases. Cancer Epidemiology and Prevention Biomarkers. 11(9). 885–889. 2 indexed citations
18.
Hayes, Richard B., Douglas Reding, William Kopp, et al.. (2000). Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Controlled Clinical Trials. 21(6). 349S–355S. 114 indexed citations
19.
Wacholder, Sholom & Patricia Hartge. (1999). Response to the Letters from Hopper and Jenkins and Foulkes et al.. The American Journal of Human Genetics. 65(6). 1775–1775. 4 indexed citations
20.
Marrett, Loraine D., Patricia Hartge, & J. Wister Meigs. (1986). Bladder cancer and occupational exposure to leather.. Occupational and Environmental Medicine. 43(2). 96–100. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026